Page last updated: 2024-10-18

imidazole and Meningioma

imidazole has been researched along with Meningioma in 1 studies

imidazole: RN given refers to parent cpd
1H-imidazole : An imidazole tautomer which has the migrating hydrogen at position 1.

Meningioma: A relatively common neoplasm of the CENTRAL NERVOUS SYSTEM that arises from arachnoidal cells. The majority are well differentiated vascular tumors which grow slowly and have a low potential to be invasive, although malignant subtypes occur. Meningiomas have a predilection to arise from the parasagittal region, cerebral convexity, sphenoidal ridge, olfactory groove, and SPINAL CANAL. (From DeVita et al., Cancer: Principles and Practice of Oncology, 5th ed, pp2056-7)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Koper, JW1
Markstein, R1
Kohler, C1
Kwekkeboom, DJ1
Avezaat, CJ1
Lamberts, SW1
Reubi, JC1

Other Studies

1 other study available for imidazole and Meningioma

ArticleYear
Somatostatin inhibits the activity of adenylate cyclase in cultured human meningioma cells and stimulates their growth.
    The Journal of clinical endocrinology and metabolism, 1992, Volume: 74, Issue:3

    Topics: Adenylyl Cyclase Inhibitors; Bucladesine; Cell Division; Colforsin; Cyclic AMP; DNA Replication; Dos

1992